Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › timolol

timolol

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of timolol

10 trials tracked of timolol: 5 in phase 3 or 4 and 3 with published results. The most-cited published study has 127 citations.

10Trials tracked
5Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 1 Phase 3 4 Phase 2 4 Other / NA 1
  1. Phase 3 Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension Completed · 127 cited
  2. Phase 3 Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension Completed · 108 cited
  3. Phase 3 Beta Adrenergic Antagonist for the Healing of Chronic DFU Completed · 19 cited
  4. Phase 4 Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Completed
  5. Phase 3 A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma. Completed
  6. Phase 2 Circadian Rhythms of Aqueous Humor Dynamics in Humans Completed
Show 4 more trials
  1. Phase 2 BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension Completed
  2. Phase 2 A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension Completed
  3. Phase 2 A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine Completed
  4. N/A A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis of tafluprost-timolol fixed-dose combination for open-angle glaucoma and ocular hypertension
Ophthalmology Meta-analysis
Meta-analysis of tafluprost-timolol fixed-dose combination for open-angle glaucoma and ocular hypertension Tafluprost-timolol drops lower eye pressure than switching to single drugs
This meta-analysis evaluated the tafluprost-timolol fixed-dose combination versus a monotherapy switch group in patients with open-angle gla…
A meta-analysis of 2066 patients found that fixed-dose tafluprost-timolol lowered eye pressure more than switching to monotherapy, with mini…
May 1, 2026
FDA Approves Cosopt Pf (dorzolamide hydrochloride-timolol maleate ophthalmic solution) for reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension
Ophthalmology FDA Approval
FDA Approves Cosopt Pf (dorzolamide hydrochloride-timolol maleate ophthalmic solution) for reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension The FDA approved a new preservative-free eye drop called Cosopt Pf for treating high eye pressure
FDA approved Cosopt Pf, a preservative-free ophthalmic solution of dorzolamide hydrochloride and timolol maleate, for reducing elevated intr…
FDA approves new preservative-free eye drop for high eye pressure in patients who don't respond well to beta-blockers.
FDA Apr 14, 2026